Small Molecule Activators of B56-PP2A Restore 4E-BP Expression and Function to Suppress Cap-dependent Translation in Cancer Cells
M. A. Lum, K. A. Jonas-Breckenridge, A. R. Black…·J. D. Black
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
M. A. Lum, K. A. Jonas-Breckenridge, A. R. Black…·J. D. Black
B. A. Krishna, A. B. Wass, C. M. O'Connor
This study identifies AP-1 transactivation of the MIE enhancer as critical for HCMV reactivation from latency, showing its role in de-repressing viral transcripts and downstream genes.
B. A. Krishna, A. B. Wass, R. Sridharan, C. M. O'Connor
This study shows US28 is required for HCMV latency, independent of US27 and US29 gene expression, using mutant viruses in hematopoietic cells.
E. G. Elder, B. A. Krishna, J. Williamson…·J. Sinclair
This study identifies that US28 downregulates interferon-inducible genes during HCMV latency, with IFI16 suppression enhancing viral gene expression via NF-κB.
B. A. Krishna, M. S. Humby, W. E. Miller, C. M. O'Connor
This paper shows that the HCMV-encoded US28 receptor promotes latency by reducing c-fos expression and AP-1 binding to the MIEP.